Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Enso logo — Solving pain without drugs or surgery

Enso

Solving pain without drugs or surgery

Founded 2013 United States San Francisco, United States 3 employees Series A Total: $7.45M Hardware, Medical Devices

General Information

Company Name Enso
Founded Year 2013
Location United States San Francisco, United States
Founders / Decision Makers
Team member
Employees 3
Industries Hardware, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Enso. To contact Enso, visit ensorelief.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Enso compare?

A PDF of Enso and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Enso soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Enso

Enso is a therapeutic neuromodulation and coaching solution startup founded in 2013, based in the United States. Their slogan, "Solving pain without drugs or surgery," encapsulates their mission to provide a non-invasive, drug-free approach to managing chronic pain. The Enso wearable device delivers electrical pulses with a specialized waveform to suppress nerve activity, offering a seamless patient experience. It is IoT-enabled with an app to track treatment use and patient progress. In April 2017, Enso secured a $4.60M Series A investment from notable investors including Freestyle Capital, Techstars, Felicis Ventures, CSC Upshot, and The Cedars-Sinai Accelerator. With the ongoing opioid epidemic, Enso's innovation provides a timely and impactful solution for individuals dealing with chronic pain, offering a sense of confidence and control in pain management.

Business keywords: Therapeutic neuromodulation, Wearable device, Chronic pain, Non-invasive treatment, Electrical stimulation, IoT-enabled, Pain management, Medical devices, Clinical research, Healthcare innovation, Opioid alternative, VA Hospital, Workers compensation, Insurance coverage

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $4.60M 5
Freestyle Capital Techstars Felicis Ventures
Freestyle Capital, Techstars +3
09 Apr 2017
Seed Round $2.85M 5
Courtside Ventures VTF Capital Duke Angel Network
Courtside Ventures, VTF Capital +3
03 Nov 2015

Enso Alternatives & Competitors

View All Alternatives
Enso vs
Avation Medical
Avation Medical United States

Avation Medical is making neuromodulation accessible through patient-friendly wearable tech like the...

Series D
90 employees
Hardware, Health Care
Enso vs
Strados Labs
Strados Labs United States

Digital Lung Acoustics for Better Insight | Cough, Wheeze, Crackles

Venture round
47 employees
AI, Digital Health
Enso vs
Acurable
Acurable United Kingdom

We create accurate and user friendly wearable medical devices intended to be used by patients at hom...

Series A
29 employees
Hardware, Health Care
View all alternatives

FAQ About Enso

Solving pain without drugs or surgery
Enso was founded in 2013.
Enso is headquartered in San Francisco, United States.
Enso operates in Hardware and Medical Devices. Its work centres on Therapeutic neuromodulation, Wearable device, Chronic pain and Non-invasive treatment.
Enso has approximately 3 employees.
Enso has completed 2 funding rounds, raising a total of $7.45M. The latest funding stage is Series A.
Top alternatives and competitors to Enso include Avation Medical, Strados Labs, Acurable, ReThink Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Enso and Avation Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Enso, https://bouncewatch.com/company/enso-3, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes